Alnylam and Sanofi Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. HTZ
6. MRK
7. TTWO
8. USO
9. QCOM
10. INFY

Go back to Alnylam and Sanofi Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 288.18 --0 (-0%)
Previous Close $288.18    52 Week High $109.10 
Open $288.18    52 Week Low $31.38 
Day High $288.18    P/E N/A 
Day Low $288.18    EPS $-1.45 
Volume 144       

GENZYME (NASDAQ: GENZ) Delayed: 36.01 --0 (-0%)
Previous Close $36.01    52 Week High $76.48 
Open $36.01    52 Week Low $65.50 
Day High $36.01    P/E 300.08 
Day Low $36.01    EPS $0.12 
Volume 4,693       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 13.60 --0 (-0%)
Previous Close $13.60    52 Week High $5.58 
Open $13.60    52 Week Low $3.60 
Day High $13.60    P/E N/A 
Day Low $13.60    EPS $0.00 
Volume 112,785       

SANOFI (NASDAQ: SNY) Delayed: 41.60 --0 (-0%)
Previous Close $41.60    52 Week High $44.76 
Open $41.60    52 Week Low $36.81 
Day High $41.60    P/E N/A 
Day Low $41.60    EPS $0.00 
Volume 24,644